Literature DB >> 18080919

Mucins in the colorectal neoplastic spectrum with reference to conventional and serrated adenomas.

Sibel Perçinel1, Berna Savaş, Arzu Ensari, Işinsu Kuzu, M Ayhan Kuzu, Mehmet Bektaş, Hülya Cetinkaya, Nazmiye Kurşun.   

Abstract

BACKGROUND/AIMS: Alterations in expression of mucins and aberrant expression of various types of mucin genes were observed in colorectal adenomas and carcinomas, though their significance in neoplastic transformation of colorectal epithelium is yet to be determined. The aim of this study was to determine expression of MUC1, MUC2, MUC5AC, and MUC6 through conventional adenoma-carcinoma sequence and polyps involved in the "serrated" pathway of the colorectum using tissue array technique.
METHODS: In this study, a total of 172 cases including 100 colorectal polyps [8 hyperplastic polyps, 10 sessile serrated adenomas, 19 tubular, 37 tubulovillous, and 26 villous adenomas], 16 adenomas with intramucosal carcinoma, 28 conventional colorectal cancers, and 28 normal mucosae were examined. Tissue array blocks were prepared and sections were stained immunohistochemically for MUC1, MUC2, MUC5AC, and MUC6.
RESULTS: Expression of MUC1 significantly increased in close correlation with the neoplastic process and reached its highest values in intramucosal carcinomas and conventional colorectal cancers (p<0.001). In contrast, MUC2 expression showed a significant decrease in intramucosal carcinoma and conventional colorectal cancer groups (p<0.001). Sessile serrated adenomas exhibited the highest MUC5AC expression while adenomatous polyps showed an increase in MUC5AC expression in parallel with neoplastic progression (p<0.001). Hyperplastic polyps seemed to lie between normal mucosa and sessile serrated adenomas in terms of mucin expression, suggesting that they are morphologically and histogenetically linked.
CONCLUSIONS: Upregulation of MUC1 and MUC6 through the adenoma-carcinoma sequence together with downregulation of MUC2 and MUC5AC at the neoplastic end of the spectrum seem to follow the steps of malignant transformation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18080919

Source DB:  PubMed          Journal:  Turk J Gastroenterol        ISSN: 1300-4948            Impact factor:   1.852


  12 in total

1.  Humoral immune response to abnormal MUC1 in subjects with colorectal adenoma and cancer.

Authors:  Ann Willman Silk; Robert E Schoen; Douglas M Potter; Olivera J Finn
Journal:  Mol Immunol       Date:  2009-02-13       Impact factor: 4.407

2.  A novel mouse model of sporadic colon cancer induced by combination of conditional Apc genes and chemical carcinogen in the absence of Cre recombinase.

Authors:  Jeffrey S Souris; Hannah J Zhang; Urszula Dougherty; Nai-Tzu Chen; Joseph V Waller; Leu-Wei Lo; John Hart; Chin-Tu Chen; Marc Bissonnette
Journal:  Carcinogenesis       Date:  2019-11-25       Impact factor: 4.944

3.  Expression of survivin, MUC2 and MUC5 in colorectal cancer and their association with clinicopathological characteristics.

Authors:  Haipeng Wang; Shengjian Jin; Huiling Lu; Sisi Mi; Wenhua Shao; Xiaoxv Zuo; Huangyi Yin; Sien Zeng; Fumio Shimamoto; Guangying Qi
Journal:  Oncol Lett       Date:  2017-05-19       Impact factor: 2.967

4.  Mucins and associated glycan signatures in colon adenoma-carcinoma sequence: Prospective pathological implication(s) for early diagnosis of colon cancer.

Authors:  Shiv Ram Krishn; Sukhwinder Kaur; Lynette M Smith; Sonny L Johansson; Maneesh Jain; Asish Patel; Shailendra K Gautam; Michael A Hollingsworth; Ulla Mandel; Henrik Clausen; Wing-Cheong Lo; Wai-Tong Louis Fan; Upender Manne; Surinder K Batra
Journal:  Cancer Lett       Date:  2016-02-16       Impact factor: 8.679

5.  Mucin core protein expression in serrated polyps of the large intestine.

Authors:  Kohei Fujita; Minako Hirahashi; Hidetaka Yamamoto; Takayuki Matsumoto; Masaki Gushima; Yoshinao Oda; Junji Kishimoto; Takashi Yao; Mitsuo Iida; Masazumi Tsuneyoshi
Journal:  Virchows Arch       Date:  2010-08-28       Impact factor: 4.064

6.  Mucins in neoplastic spectrum of colorectal polyps: can they provide predictions?

Authors:  Mahsa Molaei; Babak Khoshkrood Mansoori; Reza Mashayekhi; Mohsen Vahedi; Mohamad Amin Pourhoseingholi; Seyed Reza Fatemi; Mohammad Reza Zali
Journal:  BMC Cancer       Date:  2010-10-07       Impact factor: 4.430

7.  High-fat diets rich in saturated fat protect against azoxymethane/dextran sulfate sodium-induced colon cancer.

Authors:  Reilly T Enos; Kandy T Velázquez; Jamie L McClellan; Taryn L Cranford; Mitzi Nagarkatti; Prakash S Nagarkatti; J Mark Davis; E Angela Murphy
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-03-31       Impact factor: 4.052

8.  Mucins and associated O-glycans based immunoprofile for stratification of colorectal polyps: clinical implication for improved colon surveillance.

Authors:  Shiv Ram Krishn; Sukhwinder Kaur; Yuri M Sheinin; Lynette M Smith; Shailendra K Gautam; Asish Patel; Maneesh Jain; Vasthala Juvvigunta; Priya Pai; Audrey J Lazenby; Hemant K Roy; Surinder K Batra
Journal:  Oncotarget       Date:  2017-01-24

9.  Expression of gastric pyloric mucin, MUC6, in colorectal serrated polyps.

Authors:  Angela N Bartley; Patricia A Thompson; Julie A Buckmeier; Carole Y Kepler; Chiu-Hsieh Hsu; Manuel S Snyder; Peter Lance; Achyut Bhattacharyya; Stanley R Hamilton
Journal:  Mod Pathol       Date:  2009-10-23       Impact factor: 7.842

10.  Gastric Proteins MUC5AC and TFF1 as Potential Diagnostic Markers of Colonic Sessile Serrated Adenomas/Polyps.

Authors:  Magomed Khaidakov; Keith K Lai; D Roudachevski; Julietta Sargsyan; Hannah E Goyne; Rish K Pai; Laura W Lamps; Curt H Hagedorn
Journal:  Am J Clin Pathol       Date:  2016-11-01       Impact factor: 2.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.